The RSV vaccine Abrysvo was highly effective against hospital and ED encounters in a large cohort of older adults with comorbidities and immunocompromising conditions.

COVID-19 vaccination is associated with a reduced risk for most CV events, but with slightly increased risks for extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis ...

AI-generated responses to patient portal messages may improve workflow for nurses but not for other health care workers, a new study suggests.

The quadrivalent meningococcal conjugate vaccine MenACYW may be appropriate for invasive meningococcal disease prevention in infants as young as 6 months. A 2-dose schedule of MenQuadfi ®, a ...

Findings showed no increased risk for pregnancy, birth, or neonatal/infant outcomes with Flublok compared with standard-dose flu vaccine and estimated pregnancy outcomes for the general population.

Researchers identified 26,080 studies and determined the estimated enrollment ratio from 2018 to 2022 for all industry-sponsored versus federally sponsored trials was 8.1. HealthDay News — In the ...

Unemployment, neurological deficit, and some treatments increase the likelihood adult survivors of childhood cancer retain a fear of recurrence or SMN.

Research suggests that prior authorization has negative effects on patients with cancer and oncology providers.

Native Hawaiian and Pacific Islander adults have a high rate of cardiovascular disease mortality, according to study findings.

The FDA has approved Imuldosa, a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

The MVA-BN vaccine, licensed in the United States to prevent smallpox and mpox, is well tolerated and seems effective in adolescents.

The per member per month (PMPM) health care costs for members with insomnia were 4 to 6 times higher than those without insomnia.